PCI has unveiled its new brand identity at CPhI, reflecting the full integration of recently acquired businesses Penn Pharma and Biotec Services International, which significantly expand PCI’s drug development services. Penn Pharma, headquartered in Wales, UK. added clinical and commercial dosage form manufacturing and packaging, labeling, and global storage, distribution and return drug services. The Biotec Services acquisition also expanded PCI’s presence in the UK/EU to support globa...